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Background: External development and optical transparency of embryos make zebrafish exceptionally suitable for
in vivo insertional mutagenesis using fluorescent proteins to visualize expression patterns of mutated genes.
Recently developed Gene Breaking Transposon (GBT) vectors greatly improve the fidelity and mutagenicity of
transposon-based gene trap vectors.
Results: We constructed and tested a bipartite GBT vector with Gal4-VP16 as the primary gene trap reporter. Our
vector also contains a UAS:eGFP cassette for direct detection of gene trap events by fluorescence. To confirm gene
trap events, we generated a UAS:mRFP tester line. We screened 270 potential founders and established 41 gene
trap lines. Three of our gene trap alleles display homozygous lethal phenotypes ranging from embryonic to late
larval: nsf tpl6, atp1a3atpl10 and flrtpl19. Our gene trap cassette is flanked by direct loxP sites, which enabled us to
successfully revert nsf tpl6, atp1a3atpl10 and flrtpl19 gene trap alleles by injection of Cre mRNA. The UAS:eGFP cassette
is flanked by direct FRT sites. It can be readily removed by injection of Flp mRNA for use of our gene trap alleles
with other tissue-specific GFP-marked lines. The Gal4-VP16 component of our vector provides two important
advantages over other GBT vectors. The first is increased sensitivity, which enabled us to detect previously
unnoticed expression of nsf in the pancreas. The second advantage is that all our gene trap lines, including
integrations into non-essential genes, can be used as highly specific Gal4 drivers for expression of other transgenes
under the control of Gal4 UAS.
Conclusions: The Gal4-containing bipartite Gene Breaking Transposon vector presented here retains high specificity
for integrations into genes, high mutagenicity and revertibility by Cre. These features, together with utility as highly
specific Gal4 drivers, make gene trap mutants presented here especially useful to the research community.
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Amenability to mutagenesis combined with optical
transparency of externally developing embryos and large
clutch size make zebrafish an excellent model system for
developmental genetics [1]. Two large-scale ethylnitrosourea
(ENU) mutagenesis screens have clearly established that all
aspects of zebrafish development can be analyzed by forward
genetics [2-4]. Indeed, these large-scale screens continue to
be followed up by more specialized screens for defects in
specific biological pathways (reviewed in [5]). High efficiency
and random nature of chemical mutagenesis enables* Correspondence: darius@temple.edu
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distribution, and reproduction in any mediumgeneration of multiple alleles of variable strength, as recently
reported for tbx2b [6,7]. Constant improvements in
both mapping resources and fidelity of the assembly
of the zebrafish genome have enabled identification of
a significant subset of genes affected by chemically-induced
mutations. Nonetheless, some chemical mutants of excep-
tional biological interest remain to be cloned or confirmed.
A classic example is the hemangioblast mutant cloche, for
which only a candidate gene has been reported to date
[8,9]. Other examples are still-uncloned cocaine addiction
mutants dumbfish, jumpy and goody-two-shoes [10]. Thus,
while chemical mutagenesis can readily generate mutants in
biological pathways of interest, it does not always lead to
molecular identification of the affected genes.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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mutagenesis and does not possess as high efficiency.
However, these deficiencies are offset by more straightfor-
ward identification of affected genes using the insertional
mutagen as a molecular tag. Furthermore, it is possible to
use fluorescent reporters to monitor the expression of
mutated genes as well as design the insertional mutagen for
additional utility. The only insertional mutagen used to date
in large scale in zebrafish is the pseudotyped retrovirus.
The virus has been used in two complimentary approaches.
The first was to mutate genes required for embryonic
development, leading to identification of over 330 such
genes by a single laboratory [11-13]. The second approach
was to analyze the regulatory landscape of the zebrafish
genome through enhancer trapping [14]. Albeit successful,
retrovirus as an insertional mutagenesis vector has
several limitations. First, production and handling of
viral particles requires special expertise and facilities.
Second, modifications such as addition of gene trap
components may result in lower virus titers and require
significant optimization of production procedures [15].
Finally, the only retroviral approach that produced fluor-
escent protein expression-tagged integration events -the
enhancer trap- did not produce a significant number of
loss-of-function alleles [14].
Success of transposon-based mutagenesis in Drosophila
(reviewed in [16]) prompted investigation of the activity of
different transposons – Tc1, Sleeping Beauty and Tol2- in
the zebrafish [17-19]. In contrast to the retrovirus,
transposable elements do not possess the machinery
to deliver exogenous DNA into the nucleus, which results
in somewhat lower rates of integration into the genome
and subsequent germline transmission of transposition
events. Transposon-based insertional mutagenesis vectors
used in zebrafish fall under the general categories of
enhancer trap, 5’ gene trap and 3’ gene trap, and include
fluorescent reporters to detect “trapping” events. Enhancer
and 5’ gene trap vector integrations reveal the expression
profile of the tagged locus and are ideal for the optically
transparent, externally developing zebrafish embryos. The
drawback of enhancer trap vectors is that they usually are
not mutagenic and only induce mutations by integrations
into exons or other essential sequences of genes (reviewed
in [16]). As expected, transposon-based enhancer trap inte-
grations did not result in overt embryonic phenotypes in
zebrafish [20,21]. Initial zebrafish gene trap vectors
suffered from poor mutagenicity as well [22]. Two
reasons may underlie this lack of mutagenicity. First,
the vector used in these studies was later found to
also function as an enhancer trap [23]. Second, when
integration did occur into a gene, the splice acceptor
and polyadenylation/transcriptional termination sequences
were leaky, allowing for read-through transcription and
splicing [22,24]. This leakiness may be partly attributed touse of rabbit β-globin splice acceptor (SA) [22], as there
appear to be significant differences between mammalian
and fish splice sites [25]. To reduce this read-through
transcription and splicing, Sivasubbu and colleagues
used fish-derived SA and transcriptional termination/
polyadenylation (p(A)) sequences. Integrations into genes
were selected using the 3’ gene trap paradigm and enabled
identification of the first transposon-induced phenotypic
mutation in zebrafish, leading to adaptation of the term
“Gene Breaking Transposon” (GBT) [26]. Notably, GBTs
are capable of inducing mutations by integration into
introns of genes. This makes GBT-induced mutations
reversible by removing the SA/p(A) components.
The next step was to develop a true 5’ gene trap vector
by flanking it with a fish-derived and potentially mutagenic
SA/p(A) sequences. To make selection for integration into
protein-coding genes more stringent, the AUG translation
initiation codon of the fluorescent reporter was removed.
The 5’ gene trap cassette was flanked by loxP sites, leading
to generation of first revertible mutants in zebrafish [27,28].
An alternative mutagenesis strategy relying on integration
of trap vectors into exons or other important sequences
has also been proposed [29,30]. In parallel, Gal4-based
transcriptional activators were being adapted for insertional
mutagenesis [23,31,32]. The main advantage of Gal4-based
transcriptional activators is that gene- or enhancer-trap
lines can be used as drivers for expression of other
transgenes including fluorescent reporters, toxin genes,
calcium sensors and optically activated channel proteins, in
a tissue-specific manner [23,31,33-36].
In this study, we provide proof-of-principle demonstra-
tion that a gene breaking transposon can be equipped with
Gal4-VP16, resulting in sensitive detection of weak gene
expression. Genes involved in a variety of cellular func-
tions, from transcription to secretion, were mutated using
our Gal4-based vector. The modified gene trap is highly
mutagenic at molecular and phenotypic levels, resulting in
isolation of two embryonic lethal and one post-embryonic
lethal mutations which are revertible by Cre-mediated
recombination.
Results
Gene trap vector design and features
Our GBT-B1 (for Gene Breaking Transposon- Bipartite 1)
vector is composed of several components that in concert
ensure efficient mutagenesis, evaluation of the trapped
gene’s expression profile and enable manipulation of
resulting mutant alleles. It is based on the GBT-R15 vector
(Figure 1A) [27,28], with AUG-less mRFP (^mRFP) re-
placed by AUG-less Gal4-VP16 (^Gal4-VP16) (Figure 1B).
For direct detection of gene trap events, GBT-B1 vector
also contains a UAS:eGFP cassette [23,34,36]. In addition,
the vector has FRT, loxP and I-SceI meganuclease sites to
facilitate manipulation of insertional alleles. The loxP and
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Figure 1 Design of GBT-B1 trap. (A) Parental vector GBT-R15 [27,28]. cSA denotes carp β-actin splice acceptor, ^mRFP denotes AUG-less mRFP,
and zp(A) denotes zebrafish β-actin 3’ untranslated region and transcriptional termination / polyadenylation cassette. Tol2 5’ and Tol2 3’ are
miniTol2 transposon arms as described in [37]. (B) Features of GBT-B1 trap. ^Gal4-VP16 denotes AUG-less Gal4-VP16, and the 14XUAS:eGFP
cassette is from [34]. (C) Embryos injected with GBT-B1 without Tol2 transposase mRNA. (D) Embryos injected with GBT-B1 and Tol2
transposase mRNA.
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vector [27,28], flank Gal4-VP16 and UAS:eGFP sequences.
The two loxP sites are in direct orientation and therefore
permit excision of the gene trap leading to reversion of
the mutations, as demonstrated for GBT-R15 mutations
in gabbr1b and tnnt2 genes [27,28].
In Drosophila, P-element integrations can be converted
into deletions (deficiencies) by imprecise excision of the
transposon [38,39] (reviewed in [40]). As Tol2 transposon
does not appear to be prone to imprecise excision, we
flanked our gene trap cassette with two inverted I-SceI
meganuclease sites. While I-SceI is mainly used to facili-
tate transgenesis in zebrafish, it is used to study DNA
repair pathways in other systems [41-44]. We anticipate
that double strand breaks induced by I-SceI meganuclease
may be repaired by error-prone repair mechanisms, leading
to generation of local deletions large enough to remove
one or more coding exons of the mutated gene.
To test if our gene trap vector containing Gal4-VP16,
UAS:eGFP and additional features retained the specifi-
city of GBR-R15, we injected this vector into 1-cell
zebrafish embryos with and without Tol2 transposase
mRNA. Without Tol2 transposase mRNA, there was noexpression of eGFP (Figure 1C). When Tol2 transposase
was included, almost all embryos had GFP-positive cells,
with 20-30% expressing GFP quite highly and/or in
tissues of different embryonic origin (Figure 1D). We
concluded that GBT-B1 is unable to express eGFP unless
integrated into the genome, and therefore may have
sufficient fidelity to function as a gene trap.
Gal4-VP16 has been shown to be toxic when
overexpressed, and an attenuated version of the acti-
vator, Gal4-FF, has been shown to activate expression
of UAS-controlled transgenes in zebrafish [32,45-47].
We therefore constructed a second gene trap vector, named
GBT-B2, which contains Gal4-FF in place of Gal4-VP16.
When injected into zebrafish embryos, GBT-B2 produced
significantly lower level of eGFP expression, suggesting that
Gal4-FF is a significantly less potent transcriptional acti-
vator than Gal4-Vp16 (Additional file 1: Figure S1).
We screened 58 F0 fish injected with GBT-B2 and
failed to recover any gene traps. Gal4-FF may be too
weak a transcriptional activator to function in the context
of a highly stringent gene trap requiring a translational
fusion with the N terminus of the protein encoded by
the mutated gene.
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Integration of GBT-B1 into an intron of a protein-coding
gene in sense orientation is expected to result in a fusion
transcript between the 5’ end of the IMG (Insertionally
Mutated Gene) mRNA and Gal4-VP16 (Figure 2). If the
reading frames of the upstream exon of the IMG and
Gal4-VP16 match, a fusion protein composed of the
N-terminal portion of the protein encoded by IMG
and Gal4-VP16 will be translated. For a gene trap to be
detected, this fusion protein has to enter the nucleus, bind
the 14XUAS and activate eGFP expression. However, eGFP
expression may also result from an enhancer trap event if
the minimal promoter in front of eGFP falls under the
control of a nearby enhancer (Additional file 2: Figure S2,
see also [48]). It is critical to distinguish between gene- and
enhancer-trap events. Gene traps represent integrations
into genes that disrupt their expression, while enhancer
trap events are unlikely to be integrations into genes and
consequently unlikely to result in any loss-of-function
phenotypes. To distinguish between these two classes
of events, we have generated two 14XUAS:mRFP trans-
genic lines. In case of a bona fide gene trap event, the
IMG-Gal4-VP16 fusion protein will activate the expression
of UAS-driven mRFP in trans. In case of an enhancer trap,
eGFP is produced in the absence of Gal4-VP16 and UAS:
mRFP will not be activated.
Our first gene trap tester line, Tg(miniTol2/14XUAS:
mRFP), was established based on weak leaky expression of
mRFP in the nervous system. Leaky mRFP expression in the
absence of transactivation complicated gene trap screening,
and we no longer use this transgenic line. Our second UAS:
mRFP tester line is Tg(miniTol2/14XUAS:mRFP, γCry:GFP)
tpl2 (Tg(UAS:mRFP)tpl2 for brevity hereafter), marked by a
lens-specific GFP cassette from [19]. To reduce the possibil-
ity of mixing up putative founder or F1 gene trap fish with
Tg(UAS:mRFP)tpl2 tester fish, we bred Tg(UAS:mRFP)tpl2
onto a homozygous brass background and inject gene traps
into fish with wild type pigmentation pattern.mRNA
Protein
IMG-Gal4-VP16
fusion protein
GFP
Gal4-VP16SA zp(A) eGFP
UAS
TT
Insertion of GBT-B1 into a gene 
Figure 2 Confirmation of GBT-B1 gene traps by transactivation of UA
tester transgene on the right. Solid black boxes and lines denote exons, pa
mutated gene (IMG). Color scheme and shape used is identical to Figure 1
denotes lens-specific γCry promoter from pT2/γCry:GFP cassette pDB387 inScreening strategies
The gene trap vector DNA was mixed with Tol2 trans-
posase mRNA and injected into the yolk of 1-cell
zebrafish embryos. Injected embryos were screened
for GFP expression at 3 days post fertilization (dpf ).
Approximately 30% of embryos with the brightest
GFP expression (Figure 1D) were selected and raised
to establish an F0 pool for screening. The pilot gene
trap screen was carried out in two stages. In the first
stage, the F0 fish were incrossed, and all GFP-positive
embryos were raised. GFP-positive fish were then crossed
to Tg(miniTol2/14XUAS:mRFP) or Tg(UAS:mRFP)tpl2 to
distinguish between gene trap events (mRFP-positive) and
enhancer trap events (mRFP-negative). Seventy fish were
screened and 13 gene trap lines were established from this
work. We have also discovered at least 10 enhancer trap
events. Enhancer traps were discarded with the exception
of Et(GBT-B1)tpl1, which displayed a highly specific vascu-
lar expression pattern [48]. In the second stage of the
screen, GBT-B1-injected F0 fish were screened by crossing
to the Tg(UAS:mRFP)tpl2 line. We screened two hundred
putative F0 fish and recovered 28 gene trap events from
the second stage of the screen. Altogether, we screened
270 putative F0 fish and recovered 41 gene trap lines with
diverse expression patterns (Figure 3).
Identification of insertionally mutated genes (IMGs)
To estimate the number of integrations present in F2 fish,
we have performed Southern hybridization analysis with an
eGFP probe on a pool of 20 GFP positive and a pool of 20
GFP negative embryos from 13 different lines. The analysis
revealed that the number of transposon insertions varied
from 1 to 12 (data not shown) among different lines,
and in most of them there was only a single integration
linked to GFP.
Two complementary strategies were used to identify
insertionally mutated genes: inverse PCR (iPCR) and 5’
RACE. iPCR is the preferred method for mapping IMGs asmRFP lens GFP
mRFP UAS GFP Cry TT
UAS:mRFP in trans 
S:mRFP. A gene trap event is depicted on the left, the UAS:mRFP
le pink boxes and lines denote untranslated regions of the insertionally
. T denotes miniTol2 inverted repeats, UAS denotes 14 X Gal4 UAS, Cry
[19].
Figure 3 (See legend on next page.)
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Figure 3 Expression patterns recovered from the gene trap screen. Each gene trap line is represented by two images: brightfield and
fluorescence. Most of the lines are represented by expression pattern of the fluorescent reporter observed in 3dpf embryos, except for those lines
were reporter’s expression pattern is best visible in embryos at earlier stages of development. The latter include lines tpl8, tpl11, tpl19, tpl30, tpl34
and tpl39 for which embryos were imaged at 1 dpf, as well as lines tpl4, tpl6, tpl16, tpl21, tpl22, tpl25, tpl27, tpl28, tpl40 and tpl42 that are
represented by 2 dpf embryos.
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gene trap integration. In contrast, 5’RACE only identifies
the 5’ exon(s) of the trapped gene, but does not reveal the
exact genomic position of gene trap integration, which
makes it challenging to design genotyping primers.
iPCR analysis led to successful identification of IMGs in
21 of the lines while for the remaining 20 lines iPCR results
were inconclusive, yielding either repetitive sequences that
have multiple matches in the zebrafish genome, sequences
that mapped to short contigs devoid of protein coding
genes, or sequences that did not map onto current assembly
of the zebrafish genome. In some cases, inverse PCR failed
to produce any bands at all. For the majority of candidate
IMGs (cIMGs) identified by iPCR, the presence of a fusion
mRNA in GFP-positive but not GFP-negative embryos was
also confirmed by conducting RT-PCR with a cIMG’s
exonic primer upstream of the integration and a reverse
Gal4 primer. Fusion mRNAs were then sequenced to
verify continuity of the reading frame between the
upstream IMG exon and Gal4-VP16.
To identify additional IMGs, we performed 5’-RACE on
four gene trap lines that failed iPCR mapping: tpl3, tpl8,
tpl9 and tpl15. Similarly to iPCR, 5’ RACE was performed
on RNA from batches of 20 GFP positive embryos follow-
ing a published protocol [28]. Linkage of a given 5’ RACE
product to GFP expression was confirmed by RT-PCR on
mRNA from batches of 20 GFP-positive and GFP-
negative embryos collected independently of the 5’RACE
procedure. We successfully identified cIMGs in all four
lines. For gene trap line nudCtpl3, exons upstream of the
gene trap integration site are missing from Zv9 zebrafish
genome assembly, which explains why inverse PCR failed to
map this integration. In gene trap line zfp36l1atpl8, the
transposon integrated into a relatively short (4 kb) intron.
We were able to map the exact position of the gene trap
integration by carrying out PCR using exon primers in
combination with Tol2 inverted repeat primers. We were
unable to determine the exact position of the gene trap in-
tegration in lines nfe2l1tpl9 and eef1a1l1tpl15.
Altogether, we established 41 gene trap lines and
successfully identified IMGs linked to GFP expression
in 25 of them (Table 1, Figure 4A). In 20 cases, gene
trap integration has occurred into an intron following
an exon ending in phase 0 with respect to the gene’s
reading frame. This is the expected scenario, as the reading
frame of Gal4-VP16 in our gene trap vector is in phase 0
with respect to the splice site. Among the five cases notconforming to this expected scenario, four are inte-
grations into exons. In gene trap lines st6GalNAc5tpl5,
dkey-9i23.6tpl13 and cyp26C1tpl24, the transposon inte-
gration occurred into exons immediately following an
exon in phase 0. We did not perform RT-PCR on
dkey-9i23.6tpl13, but in gene trap lines st6GalNAc5tpl5
and cyp26C1tpl24 RT-PCR yielded fusion transcripts
consisting of the upstream exon and Gal4-VP16. This
occurs if splicing machinery skips the endogenous splice
acceptor upstream of the exon into which the gene trap
integrated and used the gene trap splice acceptor instead.
The fourth gene trap line with an exonic gene trap integra-
tion linked to GFP expression is fam46bbtpl18. In this case,
the gene trap has integrated into the first exon of the gene,
downstream of the ATG but 14 base pairs upstream of
exon/intron boundary. It is likely that another linked gene
trap integration we failed to identify may be responsible for
the GFP expression pattern. Nonetheless, fam46bbtpl18 can
be considered a null mutant of fam46bb. The fifth
non-canonical case of gene trap integration is presented
by jam3btpl7 line. In this case, gene trap integration into
the first intron of jam3b gene is linked to GFP expression,
and expression in our gene trap line closely resembles
the published expression pattern of jam3b (see zfin.org).
However, the first exon of jam3b ends in phase 1, which
should prevent translation of Jam3b-Gal4VP16 fusion pro-
tein. We confirmed this out-of-frame fusion transcript by
RT-PCR. We also observed that two gene trap integrations
were linked to GFP expression by Southern hybridization
(data not shown), indicating that additional integrations on
chromosome 21 may be responsible for the gene trap
expression pattern.
Correspondence between expression patterns of
insertionally mutated genes and fluorescent reporters
Our gene trap screen yielded a variety of expression
patterns, ranging from fairly ubiquitous to tissue-specific
(Figure 3). Expression patterns of UAS:eGFP in cis and
UAS:mRFP in trans matched very closely. Consistently with
published observations [49], eGFP expression was quicker
to appear in all gene trap lines, but mRFP expression was
more robust in later stages of development. Expression
patterns of many of the mutated genes have been previ-
ously described by others, and data has been deposited to
Zebrafish Information Network (zfin.org), including not
spatially restricted expression patterns noted for nudc
(tpl3), stat5.1 (tpl4), eef1a1l1 (tpl15) and lasp1 (tpl20).
Table 1 Molecularly identified GBT-B1 gene trap lines
Linked trap integration Zv9 integration IMG IMG-linker-^Gal4-VP16
tpl3 19:30.5 Mb nudC YRWTQSLSEVDFSRNSPGYQK
tpl4 CTGgtcagtctttgaagaggatcaggcgttcagacagacggggggcagaatctgttacagaag 3:16936744 stat5.1 GTLSAHFRNMDFSRNSPGYQK
tpl5 CTGtttctcgccatcaccatgtgcaccagtctgttgttcgtgtataacgtcagctacaataat 2:9043594 st6GalNAc5 QGYSSIIEHKDFSRNSPGYQK
tpl6 CTGcttactagtactggaatggacccgcttatgccttcagaactgccttaatccttcgtgaca 3:34884583 nsfa MATRDFSRNSPGYQK
tpl7 CTGagtgactataaatgcctgaaaaatcaactcatgtaagcacaaaatccttttgaacttttg 21:24267477 jam3b not in frame
tpl8 CTGcagctggatcagtttgtgttgtggaatgttgaggcaggctttctttctaggattaaatgc 17:37963171 zfp36l1a FDFSEMINNKDFSRNSPGYQK
tpl9 12:30.4 Mb nfe2l1 QDIMSIMELQDFSRNSPGYQK
tpl10 CTGgggtgtctgctgattcaccaagctccaaaatattgaattcctttcgtcattaaatggcct 19:7006530 atp1a3a MEDFSRNSPGYQK
tpl11 CTGtgaggctgtgtgaattttagcctcagtttcctgttctttgctgacagaagtggcacctgg 14:49326467 bbs7 CFGMKKGEAVDFSRNSPGYQK
tpl12 CTGtttaattggtgttttttatttaatagattataacagttcgggtctgacattctcatgctg 6:30448559 sgip1 GNIALSPSPLDFSRNSPGYQK
tpl13 CTGggcacatttaatgtgtctgagtcaatgccgagtgaggcaagtcaaggtcagcgaagtgat 1:45249862 dkey-9i23.6 MEEQTAKDFSRNSPGYQK
tpl14 CTGaaaattcaacaagatatgtttgattctcaatttgaagtctctgacttttgattgcagtct 16:42014825 osbpl10 SSSSVSWAVCDFSRNSPGYQK
tpl15 19:45.3 Mb eef1a1l1 PMEAANFTSQDFSRNSPGYQK
tpl16 CTGgatagaacagggtttttccccccccccacaaaccataatcgcagacaattccaacccaaa 12:44187402 ebf3 GNPRDMRRFQDFSRNSPGYQK
tpl17 CTGttagtgtatatacagtgctcggcataactggctacaacccattttgaaaatgaatatttt 16:6676846 plecb1 LLEVLSGETLDFSRNSPGYQK
tpl18 CTGggcatatcgtacaggtaaagttacaggacccatatataaaatgaaaatcagttttaaaaa 19:14006402 fam46bb Into exon 1
tpl19 CTGacaagctaacaggctaaccttaatttagttaacgtttcatcttctctcatctgctgtttg 3:28982811 fleer GEYTATVYKMDFSRNSPGYQK
tpl20 CTGtggtcaacccctcaaacaaccgccaaccccactcaccccctaggaggagaataaaaacta 3:15727276 lasp1 PTEKVNCLDKDFSRNSPGYQK
tpl21 CTGcctgagagcaagtcaagcagtctccatattgatgaggcagagaagagctgtttgactctc 19:34858311 triqk EAKRSAPGIRDFSRNSPGYQK
tpl22 CTGacatgaccagcaatttactgcagctgccattggttgtgaaaagaattagtggcatgtgcg 12:18869291 baiap2l1a SSKYEIKENEDFSRNSPGYQK
tpl23 CTGagggattcatatttgttacatttgtaaaggcgattagttgtctttaaaaagtgagtaaaa 21:6304212 fnbp1 TLWPFIKKNKDFSRNSPGYQK
tpl24 CTGgctgtagagatattaataaatatgttcaacttacttttcttttcctcttgtgcagatctc 17:19362393 cyp26c1 VGETFHWLFQDFSRNSPGYQK
tpl25 CTGagtaattaaactttgtccattgatttaataaaaaagctaattttaatactaagcaggggt 6:21614143 srp68 VDAKTKLEAQDFSRNSPGYQK
tpl26 CTGcacatacaataatatgctatttagatttgatacgtttttgttaaatagtaatattgttaa 20:4058970 fam89A AALALLRKEMDFSRNSPGYQK
tpl27 CTGctggggcgatagatagactttccagttagcactatctaatgcgatcccgtgaacagcatt 17:12186310 snap25b TRRMLQLVEEDFSRNSPGYQK
First column, gene trap line. Second column, genomic sequence adjacent to 3’ end of the gene trap integration. The capital CTG are the last three nucleotides of
Tol2. Third column, location of the gene trap integration on Zv9 zebrafish genome assembly. Fourth column, insertionally mutated gene. Fifth column, sequence
of the IMG-Gal4-VP16 fusion protein, IMG sequence is highlighted in aqua, Gal4 sequence is highlighted in magenta. The “linker” sequence is encoded by the
linker between splice acceptor and Gal4 in GBT-B1.
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ably closely match our observed expression patterns with
some notable exceptions. Several of the gene traps display
pronounced mRFP fluorescence in the yolk (tpl4, tpl9,
tpl14, tpl21, tpl26, tpl35, tpl39), while gene expression in
the yolk is not typically observed by in situ hybridization.
This may be non-specific, or may reflect accumulation of
fluorescent protein from maternal contribution or from
earlier gene expression in yolk syncytial layer. A separate
subset of gene traps displays mRFP expression in the noto-
chord (tpl5, tpl17, tpl18, tpl31, tpl32) at 3 dpf. Similarly to
yolk, notochord is not a prominent expression domain
when gene expression at 3 dpf is analyzed by in situ
hybridization (zfin.org and [50]). mRFP expression in the
notochord may be a remnant of earlier expression, or may
reflect non-specific background. A particularly instructive
example is presented by the baiap2l1atpl22 gene trap. By in
situ hybridization, baiap2l1a is expressed in the peridermand notochord before but not after the 25-somite stage. In
2-day embryo, baiap2l1a is expressed in the pronephric
duct, in the general area of the pharynx and in the brain
(zfin.org and [50]). In contrast, mRFP expression in
the skin and the notochord is observed through 3 dpf
in baiap2l1atpl22 gene trap line, in addition to highly
pronounced expression in the areas of kidney tubules,
pharynx and lower jaw (Figure 3). It has been noted that
turnover of mRFP in vivo is very slow [49], which may
explain the presence of UAS-driven mRFP but not baiap2l1a
mRNA in the skin and the notochord at 3 dpf.
In the nsfatpl6 gene trap line, we observed expression
of GFP throughout the developing nervous system in a
pattern largely consistent to the previously reported
expression of nsfa [51,52]. However, the gene trap line
nsfatpl6 also expresses GFP and RFP in the pancreas
(Figure 3). To investigate if this pancreatic fluorescent
protein expression corresponds to endogenous expression
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Figure 4 Characterization of GBT-B1 gene trap events at the molecular level. (A) Schematic illustration of molecularly characterized gene
trap events. Gene trap integration is indicated by an open triangle. Exons upstream of gene trap integration are shown as black (coding exons) or
grey (non-coding exons) boxes. Exons downstream of gene trap integration are shown as open boxes. Integrations into jam3b and fam46bb are
not shown because they do not form in-frame fusions with the upstream exon. (B) Levels of wild-type transcript present in homozygous gene
trap mutants.
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using a DIG-labeled riboprobe antisense to nsfa. Robust in
situ hybridization signal in the nervous system was
detectable after a short staining period. Longer incubation
yielded a clear hybridization signal in pancreas as well
(Additional file 3: Figure S3). This indicates that endogenous
nsfa transcript is present in the pancreas. Relatively low
abundance of nsfa transcript in the pancreas compared to
the nervous system explains why it was missed by
previous studies in zebrafish. Importantly, nsf is known to
be expressed in human pancreatic beta-cells [53].
While all of our Gal4 gene traps can be used as drivers
to express other transgenes in tissues expressing mRFP
(Figure 3), lines displaying restricted neuronal expression
are of particular interest given presence of well-established
Gal4/UAS based tools to modulate and detect neuronal
activity [32,35,54-57]. We therefore decided to test how
closely expression of mRFP in trans corresponds to the
endogenous expression of three genes expressed in over-
lapping but different neuronal domains: ebf3, cyp26c1 and
snap25b (Figure 5). We found that expression of mRFP
largely corresponds to the expression of endogenous
gene, but in an incomplete and/or mosaic pattern. Incom-
pleteness of mRFP expression compared to the endogenous
expression may in part be due to the delay in mRFP
fluorescence because of slow maturation of mRFP as
well as the additional step of transcriptional activation
by Gal4-VP16. Mosaicism of mRFP expression compared
to the expression of endogenous gene is most likely due to
partial silencing of Gal4 UAS. Thus, while BGT-B1 gene
traps can be used as highly specific Gal4 drivers, add-
itional steps should be taken to ensure that the transgeneof interest is indeed expressed in the cells that are being
targeted.
Assessment of mutagenicity at the molecular level
One of the key questions regarding any mutagenesis strat-
egy is the ability to generate complete loss-of-function
(null) alleles. Reverse genetic strategies such as tilling, zinc
finger nucleases and TALEN nucleases in zebrafish and
homologous recombination in the mouse are designed
to ensure physical disruption of exons or splice sites,
which greatly increases the probability of complete
loss-of-function alleles. Generation of loss-of-function
alleles by GBTs relies on the efficiency of the vectors
splice acceptor and transcriptional termination signals
in a given genomic context. To assess the mutagenic
efficiency of our system, we have performed qRT-PCR
to quantify the levels of wild type read-through transcript
in 9 lines (Figure 4B). Expression levels were compared
between three or four homozygous mutant embryos and
three wild type siblings at 5 dpf. In four out of six lines, the
amount of wild type transcript was below 1%, while one
additional line had wild type transcript at almost 4%. In the
remaining four lines, the amount of wild type transcript
ranged from 9.5% to 32%.
It should be noted that lines harboring integrations into
exons - st6GalNAc5tpl5, dkey-9i23.6tpl13, fam46bbtpl18 and
cyp26C1tpl24 - were excluded from this qRT-PCR analysis
because wild type transcript cannot be produced in these
lines. We also excluded the gene trap line flrtpl19, because
it had a severe embryonic phenotype suggestive of a null
phenotype (see below). It is difficult to unequivocally
interpret levels of tissue-specific specific transcript between
tpl16 ebf3
tpl24 cyp26c1
tpl27 snap25b
A B
C D
E F
Figure 5 Comparison between patterns of UAS-driven mRFP fluorescence and endogenous gene expression by whole mount in situ
hybridization. Embryos containing ebf3tpl16, cyp26c1tpl24 and snap25btpl27 gene traps and Tg(UAS:mRFP)tpl2 reporter where photographed on
Zeiss AxioImager microscope at 30–32 hpf (A, C, and E respectively). Expression of endogenous genes detected by whole mount in situ
hybridization using antisense probes against ebf3 (B), cyp26c1 (D) and snap25b (F) on 30 hpf embryos.
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defects.
Assessment of mutagenicity at the phenotypic level
To test for overt homozygous phenotypes, we have in-
crossed F2 or later generation heterozygous siblings from all
gene trap mutant lines. Embryos were checked for overt phe-
notypes at 1 dpf, 3 dpf, 5 dpf. Two of our gene trap lines are
insertional alleles of genes with previously characterized
chemically-induced mutations: nsfatpl6 and flrtpl10. All
incrosses of nsfatpl6 heterozygotes resulted in approximately
25% of embryos displaying failure to inflate the swim bladder
and a progressive paralysis phenotype consistent with the
previously published phenotype of nsfast25 and nsfast53 [51]
(Additional file 4: Figure S4A and Additional file 5: Movie 1).
PCR genotyping confirmed that all paralyzed embryos with
non-inflated swim bladders were homozygous for the nsfatpl6
gene trap allele (data not shown). Similarly, all incrosses of
flrtpl10 heterozygotes resulted in 25% of embryos displaying
abnormal body curvature and kidney defects similar to the
phenotype of flrm477 homozygous mutants [58] (Additional
file 4: Figure S4B and Additional file 6: Movie 2).To test for postembryonic lethality, we raised GFP-
positive fish from incrosses of 8 additional gene trap
lines: nudCtpl3, stat5.1tpl4, st6GalNAc5tpl5, zfp36l1atpl8,
nfe2I1tpl9, atp1a3atpl10, bbs7tpl11 and sgip1tpl12. For gene
traps that do not affect survival of homozygotes, we
expected 1/3 of adult fish to be homozygous and 2/3 fish
to be heterozygous for the gene trap. In all but one line
(atp1a3atpl10) we observed the expected Mendelian ratio
of homozygous mutants versus heterozygous fish. In the
atp1a3atpl10 gene trap line, no homozygous mutants
were identified after genotyping the initial clutch of 14
GFP-positive adult survivors, even though homozygous
embryos did not display overt phenotypes at 5 dpf
(Additional file 7: Figure S5). We then followed the
survival rate among 86 GFP positive embryos from 4
different clutches of heterozygous in-cross over a
period of one month. We discovered that a severe drop in
survival occurred between 8 dpf and 10 dpf with no
further change beyond 20 dpf. Forty five percent (42/86)
of larvae survived to one month. We then genotyped adult
fish (n = 24) from two additional clutches and failed to find
homozygous mutants among them. Together with the initial
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instead of the expected ratio of approximately 13/38
(p < 0.001). This phenotype is consistent with postembryonic
lethality observed in atp1a3 mutant mice [59].
Morpholino (MO) knockdown phenotypes have been
published for two mutants recovered in our screen,
atp1a3atpl10 and bbs7tpl11 [60,61]. Morpholino knockdown
of Atp1a3a resulted in dilated brain ventricles and electro-
physiological defects in Rohon-Beard neurons, resulting in
defective touch response [61]. In incrosses of atp1a3atpl10
heterozygotes we did not observe embryos with severely
dilated (or otherwise morphologically defective) brain
ventricles, but we have not assessed them for more subtle
defects (Additional file 7: Figure S5A). We also did not ob-
serve severe touch response defects reported in morpholino
injected embryos at 60 hpf. However, larval lethality of
atp1a3atpl10 homozygotes clearly supports an essential role
for Atp1a3a in neural development and/or physiology.
For bbs7, Yen and colleagues observed absent or reduced
Kupffer’s vesicle (KV) in 28.1% of embryos injected with
500 μM solution of morpholino. The percentage of
embryos with KV defects was reduced to 6.7% when 250
μM solution of the same morpholino was used, indicating
that this phenotype was highly dose-dependent. We did
not observe a significant fraction of embryos with KV
defects in bbs7tpl11 heterozygous incrosses (data not shown).
Yen and colleagues also noted that approximately 14% of
embryos injected with either 250 μM or 500 μM solution of
bbs7 morpholino displayed defects in cardiac jogging: the
first morphologically observable indication of left-right
patterning [60]. In our incrosses of bbs7tpl11, we observed a
low percentage (<5%) of embryos with heart looping
or jogging defects or delay at 1 dpf, but a majority of
these embryos had normal hearts by 3 dpf. Notably,
embryos homozygous for bbs7tpl11 retained over 9% of
full-length transcript, and the level of endogenous full-
length bbs7 transcript varied 14-fold among homozygous
embryos while the variation was only 2-fold among wild
type controls. Furthermore, bbs7tpl11 homozygotes are vi-
able and fertile. Based on these observations, we believe
that bbs7tpl11 is a hypomorphic allele. Hypomorphic nature
of bbs7tpl11 allele explains why we did not observe pheno-
types nearly as severe as noted for high-dose morpholino
knockdown. It has also been suggested that mutations in
modifier genes are required for full penetrance of
Bardet-Biedl Syndrome [62-65], making it possible
that the observed bbs7 MO phenotypes may be specific to
the genetic background in which they were observed.
Reversion of gene trap mutations by Cre recombinase
The internal components of the GBT-B1 vector (the gene
trap cassette and the UAS:eGFP cassette) are flanked by
loxP sites in direct orientation, analogously to the arrange-
ment in GBT-R15 and GBT-RP2 [27,28]. Since mutagenicproperties of gene breaking transposons are brought about
by the splice acceptor and polyadenylation/transcriptional
termination signals, removal of these components should
lead to reversion of the insertional mutation.
To test the efficacy of gene trap excision by Cre
recombinase, we crossed nsfatpl6 to Tg(UAS:mRFP)tpl2
homozygotes and injected 25 pg of in vitro transcribed
Cre mRNA into the yolks of 1-cell embryos. We found
that Cre recombinase was extremely efficient at excising
the gene trap cassette, as evidenced by mosaic and
nearly complete loss of both mRFP and eGFP expression
in Cre-injected embryos (Figure 6A, B). We then tested
if this Cre activity is sufficient to revert mutant phenotypes
in injected embryos. We injected 75 pg of in vitro tran-
scribed Cre mRNA into the yolks of 1-cell embryos
obtained from incross of gene trap (nsfatpl6, flrtpl10 and
atp1a3atpl10) heterozygotes. For nsfatpl6 and flrtpl10, we then
prepared DNA from individual non-paralyzed 5 dpf
embryos with inflated swim bladders and performed PCR
genotyping for gene trap homozygocity. In both cases, we
found 5/24 genotyped embryos to be homozygous for the
gene trap (data not shown).
For atp1a3atpl10, we scored Cre-injected embryos for
GFP and raised GFP-positive embryos to adulthood. Adult
fish were genotyped, and 3/10 were found to be homozy-
gous for the reverted atp1a3atpl10R allele (data not shown),
demonstrating efficient reversion of the mutant allele.
Removal of UAS:eGFP by Flp recombinase
Our gene trapping cassette has a built-in UAS:eGFP com-
ponent, which allows instant visualization of the trapped
gene’s expression pattern. To increase versatility of our
mutant lines, we have flanked UAS:eGFP sequences by
direct FRT sites. Upon expression of Flp recombinase,
recombination between the FRT sites would result in
excision of the UAS:eGFP reporter without affecting the
mutagenic Gal4-VP16 component. Excision of the eGFP
reporter would make the GFP channel available for
utilization in other GFP-reliant transgenic applications. For
the proof-of-principle of Flp-recombinase functionality, we
injected 600 pg of in vitro transcribed Flp recombinase
RNA into the yolks of 1-cell embryos heterozygous for the
nsfatpl6 gene trap and containing Tg(UAS:mRFP)tpl2. As
expected, injection of Flp mRNA did not lead to reduction
of mRFP expression. Somewhat surprisingly and in contrast
to injection of Cre mRNA, a majority of the embryos did
not display a significant reduction in eGFP expression
either. Only about 10-15% of the embryos displayed
significant loss of eGFP (Figure 6C, D). Embryos with
significantly reduced GFP expression were raised to
adulthood and six resulting adults were outcrossed to
Tg(UAS:mRFP)tpl2. Germline-transmited Flp-mediated
UAS:eGFP excision events were scored by complete
absence of eGFP expression in the presence of mRFP.
AC
B
D
Figure 6 Manipulation of the nsfatpl6 gene trap using Cre and Flp recombinases. Embryos containing the nsfatpl6 gene trap and UAS:
mRFPtpl2 were injected with 25 pg of Cre (A, B) or 600 pg of eFlp (C, D) mRNA. Groups of four representative embryos, with the bottom embryo
representing low recombinase activity. Note simultaneous loss of GFP and RFP in panels A and B (injection of Cre RNA), and loss of GFP without
loss of RFP in panels C and D (injection of eFlp RNA).
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of eGFP expression in the germline (Additional file 8:
Table S2). As expected, the Flp-deleted allele of nsfatpl6
retains the ability to activate Tg(UAS:mRFP)tpl2 in trans,
and 50% of embryos display mRFP expression. We
conclude that UAS:eGFP cassette can be readily removed
from GBT-B1 gene trap lines.
Discussion and conclusions
The main principle underlying our insertional mutagenesis
system is shared with the recently reported 5’ gene trap
vectors GBT-R14, R15 and R16 [27,28], which use highly
efficient splice acceptor and polyA to disrupt endogenous
transcripts and mRFP to visualize the mutated gene’s
expression pattern. We have expanded the versatility
of these gene-breaking transposons by splitting the
expression-reporting core into two separate entities.
We have replaced mRFP with Gal4-VP16 in the mutagenic
entity of the vector. To report the presence of Gal4-VP16
we included a Gal4 UAS reporter (UAS:eGFP). The UAS:
eGFP component is removable by Flp recombinase for
situations where the GFP channel is needed for other
purposes such as visualization of another transgene.
Replacement of mRFP with Gal4-VP16 serves a dual
purpose. First, transcriptional activator property of Gal4-
VP16 amplifies the signal of the trapped gene, enabling
visualization of low level IMG expression. For example,
Gal4-VP16 dependent GFP and RFP expression was
observed in the pancreas of the nsfatpl6 gene trap line – anorgan which was previously not known to express nsfa.
Second, while mutant lines with no phenotype have rather
limited research value, our “non-phenotypic” gene trap lines
can be used as Gal4 drivers for ectopic expression of any
UAS-controlled transgene of interest. Notably, neither
epigenetic silencing of UAS:eGFP nor removal of UAS:
eGFP by Flp affect the ability of our gene traps to act as
Gal4 drivers. Furthermore, the standard considerations
apply when using our gene traps as Gal4 drivers: the UAS:
driven transgene may be affected by silencing in some or all
tissues, and it may or may not express in any individual cell,
as illustrated for mRFP in Figure 4. In that sense, our gene
traps are not different from previously published Gal4
enhancer- and enhancer/gene-traps [23,31,32]. We would
like to note that compared to enhancer traps with hsp70
minimal promoter, our gene trap does not exhibit
background expression in non-specific tissues such as
the heart and the muscle.
The use of Gal4-VP16 as the primary gene trap reporter
may also raise some concerns. It has been noted that
Gal4-VP16 can be toxic when expressed at high levels
[32,45-47]. We recovered several lines with very high
levels of fluorescent reporter (GFP and RFP) expression,
for example tlp26, tpl37 and tpl39, and did not observe
overt phenotypes in incrosses of these lines. Furthermore,
there is a significant difference in how Gal4-VP16 is
expressed between different experiments. Our gene traps
produce fusion protein under the control of a single-copy
endogenous promoter, while other experiments used
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tiple copies. In our gene trap lines Gal4-VP16 is expressed
as a fusion protein with the N terminus of the protein
encoded by the endogenous gene, which is not usually the
case in other experimental paradigms. Together with the
observation that Gal4-FF is inactive in our gene trap
context, our data argues that the strength of Gal4-VP16 is
just right for our gene trap context, and that expression levels
our gene traps achieve are unlikely to cause of toxicity.
Another potential concern for using Gal4-VP16 as
the primary gene trap reporter is that expression of
UAS-controlled transgenes are susceptible to variegation
and silencing in zebrafish [47,66]. To circumvent this prob-
lem, we employ a second reporter, UAS:mRFP, to ascertain
the presence of the gene trap allele. We also tend to select
high expressors when we propagate our gene trap lines.
Nonetheless, after F5 generation, we no longer observe GFP
expression in several lines including ebf3tpl16 and fnbp1tpl24.
Despite of loss of GFP expression, these gene trap
lines can still be used as Gal4 drivers, as they suc-
cessfully transactivate UAS:mRFP. Replacing the 14XUAS
with a less repetitive variant such as nrUAS [66] may be
worthwhile if sensitivity for low expression levels can
be retained.
The third potential concern for using Gal4-VP16 as the
reporter may be the requirement that IMG-Gal4-VP16
fusion proteins must enter the nucleus, bind the DNA and
activate transcription. This excludes a significant subset of
genes as potential targets. For example, Gal4-VP16 fusions
with proteins containing amino-terminal signal peptide
would be unable to enter the nucleus. Such proteins
constitute about a fifth of vertebrate proteomes [67].
Many other protein domains have been noted to affect
protein localization within the cell. We were concerned
that use of Gal4-VP16 as the primary reporter will intro-
duce significant bias in intracellular functions of trapped
genes, such that we would mainly target transcription
factors and other proteins which primarily function in the
nucleus. While the subset of trapped genes presented here
is too small to exclude or confirm the possibility of such
bias, we note that among the trapped genes, two are
components of the SNARE complex involved in secretory
pathway (nsfa and snap25), and two are involved in cilia
biogenesis (bbs7 and fleer). Thus, genes involved in a
variety of cellular processes can be mutated using our
vector. Furthermore, GBT-R15 and GBT-RP2 are especially
suitable for trapping genes coding for secreted proteins [28],
making our Gal4-VP16-based approach complementary.
It would be possible to expand the repertoire of genes
amenable to trapping using Gal4-VP16 (e.g. eliminate
bias against proteins with N-terminal signal sequence) by
using viral P2A/T2A co-translation systems demonstrated
to work in zebrafish [68,69]. We do not favor this strategy,
since there appears to be a positive side effect of usingGal4-VP16 as the primary gene trap reporter. Among
gene trap lines we characterized, six have integrations into
intron 1, and two additional lines have integrations into
exon 2, which effectively results in fusion transcript with
exon 1 (Figure 4A). Gene traps using fluorescent reporters
do not appear to have a similar 5’ bias [22,27,28,70,71].
The 5’ bias of our vector is likely brought about by the
requirement that IMG-Gal4-VP16 fusion protein must
enter the nucleus, bind DNA and activate transcription of
eGFP and mRFP under the control of Gal4 UAS. One or
more of these functions may be compromised by addition
of a large polypeptide with one or more functional
domains. As a consequence of this 5’ gene trap bias,
a shorter part of the endogenous gene is expressed, which
increases the likelihood of null alleles. Inclusion of
P2A/T2A would eliminate this beneficial bias of Gal4-VP16
gene traps toward 5’ ends of genes.
Efficient mutagenic potential of our vector is observed
at both molecular and phenotypic level. Among the 25
molecularly characterized lines, four are integration into
exons and therefore null alleles. Almost half the lines
analyzed by RT-PCR (4/9) display wild type transcript
levels below one percent and therefore should be consid-
ered null alleles as well. A fifth has wild type transcript
level below five percent, making it a possible null
mutant, too. The flrtpl10 line was not analyzed by RT-PCR
due to developmental abnormalities but displays a homo-
zygous phenotype very similar or identical to that of the
corresponding chemically-induced null mutant. Thus, it is
safe to assume that well over 50% of mutants recovered
with GBT-B1 will be null alleles. How does it compare to
other published insertional mutagenesis systems? Assess-
ment of mutagenicity of the only insertional mutant used
in large scale in zebrafish so far, the pseudotyped retro-
virus, demonstrated that 4/10 integrations into intron 1
resulted in transcript levels below 5%, while 1/8 integra-
tions immediately upstream transcription start site and 0/
5 integrations into other introns produced likely null
alleles [72]. A more appropriate comparison would be
with other transposon-based insertional mutagenesis
systems. Unfortunately, mutagenicity of most other trans-
poson systems was not systematically assessed at the
molecular level [22,32,71]. Recently published Flex-based
vectors reduced the levels of endogenous transcript to just
below 7% [70], which is easily surpassed by our vector. It is
also interesting to note that GBT-B1 appears to be more
mutagenic than the parental vector GBT-R15 [27,28]. This
may be caused by the addition of the UAS:eGFP cassette.
Even though this cassette is in antisense orientation in the
trap, the SV40 p(A) used to terminate transcription of
eGFP is bidirectional [73]. Even though SV40 p(A) is not
efficient enough to cause mutations on its own [26],
it may contribute to reduction in endogenous transcript.
Furthermore, several potential splice acceptor sites can be
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cassette (http://wangcomputing.com/assp/index.html [74]).
It is also possible that replacement of ^mRFP with ^Gal4-
VP16 added an exonic splice enhancer or removed an
exonic splicing silencer [25], thus improving the efficiency
of the short carp β-actin splice acceptor used in both
vectors. Each of these factors may account for the
minor increase in mutagenicity of GBT-B1 compared
to GBT-R15. However, mutagenicity of GBT-B1 is
clearly lower than that of GBT-RP2 [28]. GBT-RP2
contains an additional carp β-actin splice acceptor in
the 3’ gene trap component of the vector, which may
contribute to higher mutagenicity of this vector. GBT-RP2
vector also uses a poly (A) which is derived from ocean
pout antifreeze gene and is thought to contain a potential
boundary element [75]. It would be interesting to test if
replacement of zebrafish β-actin p(A) with ocean pout
antifreeze p(A) would increase the mutagenicity of our
vector to RP2 knockdown levels, or if an additional splice
site would still be required.
While qPCR provides the precise degree of gene inactiva-
tion at the molecular level, the level of disruption needed to
achieve a loss-of-function phenotype is likely to be different
from gene to gene. Loss-of-function chemically-induced
mutants have been previously described for two of the
genes mutated in our screen, nsfatpl6, flrtpl10. In both cases,
the phenotypes of our insertional mutants appear to be
indistinguishable from corresponding chemically-induced
alleles [51,58]. Interestingly, gene trap integrations in
these two genes have occurred into the first intron.
Only 4/744 and 18/651 amino acids are retained by
Nsfa- and Fleer-Gal4-VP16 fusion proteins, respectively.
Our mutagenesis system offers an ability to condition-
ally revert mutagenic insertions into non-mutagenic ones
by Cre-recombinase mediated excision of the Gal-VP16
(and UAS:eGFP) sequences. Reversion of mutations by
injection of Cre mRNA is very useful in determining
causal relationship between gene trap integrations and ob-
served phenotypes. Tissue- and/or time-specific reversion
of the mutation attained by breeding gene trap mutants to
lines expressing CreER or CreERT2 in a tissue-specific
manner would enable dissection of spatiotemporal
requirement of the trapped gene. This functionality
gives mutant alleles made with GBT-B1 an advantage
over alleles made chemically, with various targeted
nucleases, or with retrovirus. However, it would be
even more beneficial to combine the high mutagenicity of
GBT-B1 (perhaps improved to GBT-RP2 levels) with the
full conditionality offered by two-recombinase inversion
systems such as FleX, recently adapted for use in zebrafish
[70,71]. Combination of additional functionality offered by
Gal4-VP16 with high mutagenicity and full conditionality
would provide a very powerful tool for dissection of gene
function in the zebrafish.Methods
Construction of vectors
To build our gene trap vector and UAS:mRFP reporter
transgenes, we used GBT-R15 [27,28], components of
Gal4-VP16 vectors generated by the Fraser laboratory
[34], miniTol2 [37], lens-specific GFP expression cassette
γCry:GFP [19] and monomeric Red Fluorescent Protein
(mRFP) [76]. Details on vector construction are available
upon request. The gene trap construct GBT-B1
(Gene Breaking Transposon – Bipartite 1, pDB783)
and Tol2/γCry:GFP,14XUAS:GFP (pDB790) are available
from Addgene. To produce GBT-B2, the VP16 transcrip-
tional activation domain was replaced by VP16-FF by PCR.
Transgenesis procedures
Gene trap construct GBT-B1 (pDB783) was purified
using Qiagen miniprep protocol including the optional
PB wash step. Plasmid DNA (25 pg) was co-injected
with 25 pg of Tol2 RNA into 1-cell zebrafish embryos in
standard Tol2 transgenesis protocol [37,77]. Embryos
injected with GBT-B1 were screened on Zeiss Axioscope
or Zeiss Axioimager (both with 5X Fluar objective) for
high levels of GFP fluorescence at 3 dpf. Approximately
20-30% of embryos surviving to day 3 were considered
high expressors and raised to adulthood. The same
methods were applied to generate the Tg(Tol2/14XUAS:
mRFP) line, embryos were injected with pTol2/14XUAS:
mRFP (pDB788) with Tol2 transposase mRNA and
raised to adulthood. Adults were incrossed and embryos
were screened for leaky expression of mRFP. A single
transgenic line was established. To produce Tg(Tol2/
gCry:GFP,14XUAS:mRFP)tpl2 line, we injected embryos
with Tol2 mRNA and Tol2/gCry:GFP, 14XUAS:mRFP
(pDB790), screened for GFP expression in the lens and
raised to adulthood. Adults were incrossed and embryos
were screened for lens-specific GFP expression. A single
transgenic line was established.
Inverse PCR
Genomic DNA was prepared from batches of 20 GFP posi-
tive and GFP-negative embryos from an F1 or F2 outcross.
In separate reactions, the genomic DNA was digested with
NlaIII, TaqI, NheI/SpeI/XbaI/XmaJI or BamHI/BclI/BglII,
then diluted and ligated overnight as described in [28,78].
Several different primer combinations were used in inverse
PCR. For most lines, the first PCR reaction was carried out
using primers Tol2-F13 and Tol2-R4 (primer sequences
are listed in Additional file 9: Table S1). 0.1-1uL of the first
PCR was used to carry out the second PCR reaction using
primers Tol2-F11 and Tol2-R5. To identify genes mutated
in tpl17, tpl23 and tpl25, two sets of inverse PCR reactions
were carried out. For 5’ end of the gene trap, first PCR was
carried out with Tol2-F8 and B1/5’No3 and the second
PCR was carried out with Tol2-F4 and B1/5’No2. For 3’
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and B1/3’No1 and the second PCR was carried out with
Tol2-R4 and B1/3’No2.Identification of Gal4 fusion transcripts by 5’RACE
Total RNA was prepared from a pool of 20 GFP positive
and a pool of 20 GFP negative 5 dpf embryos using
Absolutely RNA miniprep kit (Agilent Technologies,
Cat# 400800). cDNA was made from 250-500 ng of
total RNA using SuperScript™ II Reverse Transcriptase
(Invitrogen, Cat # 18064–022) following previously
described protocol [28,79]. Race-ready cDNA was ampli-
fied by PCR using primer mix containing KJC-002 and
KJC-003 at a ratio of 1:5 and Gal4-R2. Second PCR
reaction was performed using either 1 μL of undiluted or 1
μL of 1:10 dilution of the first PCR, using KJC-004 and
Gal4-R3 primers. PCR products from the second PCR
reaction were run on 1% agarose gel, and bands obtained on
GFP-positive embryo DNA but absent from GFP-negative
siblings were purified using either Qiagen or Thermofisher
Fermentas Gel Extraction kits and sequenced.Confirmation of Gal4 mRNA fusion by RT-PCR
Once gene trap integration linked to GFP expression
was identified by iPCR (or 5’RACE), the presence of
Gal4 mRNA fusion was confirmed by RT-PCR. For this,
cDNA was made from 250-500ng of total RNA prepared
from a pool of GFP positive 5 dpf embryos using
SuperScript™ III Reverse Transcriptase (Invitrogen, Cat #
18080–044) and random hexamers following protocol
supplied by the manufacturer. 1 μl of the cDNA was
used for PCR amplification using forward genomic
primer for an exon upstream of the integration and a
reverse primer for Gal4 (Gal4-R2 or Gal4-R3). PCR
bands were sequenced with Gal4 reverse primer to
confirm correct reading frame of the fusion mRNA.Southern Hybridization
Genomic DNA was prepared from a pool of 20 GFP
positive and a pool of 20 GFP negative 5 dpf F2 generation
embryos from 13 gene trap lines (tpl3, tpl4, tpl5, tpl6,
tpl7, tpl8, tpl9, tpl10, tpl11, tpl12, tpl13, tpl14, tpl15).
Genomic DNA (5 μg) was digested with HpaI and NdeI,
subjected to 1% agarose gel electrophoresis and trans-
ferred onto Amersham Hybond™-XL (GE Healthcare,
code RPN303S) membrane. Hybridization was carried
out with 32P-labelled eGFP probe (ca 700 bp) that was
obtained by PCR amplification using original gene trap
vector as a template.
For tpl6 and tpl10 lines, additional Southern analyses
were performed on genomic DNA digested with HindIII,
NsiI and HindIII/NsiI.Genotyping
Genotyping strategy was designed for gene trap insertions
with known genomic integration sites. Genotyping was
typically performed using three-primer PCR: forward
genomic primer upstream of the integration, reverse gen-
omic primer downstream of the integration, and a gene
trap (Tol2) primer. Wild type allele produces an amplicon
between two genomic primers, while the gene trap allele
gives rise to a product between the gene trap primer and
one of the genomic primers. Primers were selected so that
wild type band and gene trap band would differ in size.
For an example, see Additional file 7: Figure S5, lanes 17
and 18. Primer sequences are listed in Additional file 9:
Table S1, and exact genotyping PCR conditions are avail-
able upon request. In cases where three-primer PCR failed,
standard two primer PCR was performed using one
transposon primer and one genomic primer on gene
trap positive and gene trap negative embryo DNA.
RT-qPCR
RT-qPCR was used to determine the efficiency of mRNA
knockdown of insertionally mutated gene by quantifying
relative amount of intact mRNA present in homozygous
mutants versus wild type siblings. DNA and RNA were
isolated from 3 GFP-negative and 10–15 GFP-positive 5
dpf embryos using Trizol reagent (Ambion). DNA fraction
was used for genotyping, and RNA was used to prepare
cDNA from 3 wild type and 3–4 homozygous mutant
siblings. qPCR was carried out using LightCycler® 480
SYBR Green I Master kit (Roche, Cat # 04707516001) with
genomic primers for trapped gene’s exons flanking the
transposon integration. Each sample was analyzed in tripli-
cates. β-actin was used as a “reference” gene to normalize
for differences in cDNA yields. PCR conditions were as
follows: 5 min initial incubation at 95°C, followed by 42
cycles of 95°C for 10 sec, 57°C for 15 sec and 72°C
for 1 min, and ending with a final step at 72°C for 7 min.
qPCR data were analyzed using LightCycler® 480 1.5 soft-
ware. Expression levels of intact mRNA of the mutated
gene (”target” gene) for each sample were calculated as
ratio of CT values for “target” and “reference” genes,
averaged over triplicates assuming equal PCR amplification
efficiencies (=normalized expression) [80]. Genotyping and
qPCR primers are listed in Additional file 9: Table S1.
In situ hybridization
Analysis of co-expression of endogenous nsfa transcript
with eGFP was performed by whole-mount in situ
hybridization on 1 dpf embryos as described previously
[50]. nsfa full-length cDNA was obtained by PCR ampli-
fication using primers nsf/kpn-F1 and nsf/Cla-R1 and 5
dpf embryo cDNA as the template. The 2.2 kb PCR
band was cloned into the pCR®II-TOPO® vector
(Invitrogen K4600-01). Resulting plasmid was linearized
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DIG RNA Labeling kit (Roche 11 175025910) with T7
RNA polymerase in 20 μL of reaction volume. The
reaction was carried out at 37°C for 2 h, and incubated for
additional 15 min with 2 μl of DNase I at the same
temperature. RNA was precipitated by adding 2 μL of 7.5 M
Lithium Chloride and 75 μl of 100% ethanol following incu-
bation at −20°C overnight. Following centrifugation, RNA
pellets were washed with 70% ice-cold ethanol and
dissolved in 30 μl of RNase-free water. eGFP probe was
obtained by PCR amplification with ^eGFP-F1 and
Cla/BGYFP-R1 (primer sequences are in Additional file 9:
Table S1) using GBT-B1/pDB783 as a template. Probes for
ebf3, cyp26c1 and snap25b were PCR amplified from 5 dpf
embryo cDNA using corresponding primers listed in
Additional file 9: Table S1. All subsequent steps were
the same as described for nsfa probe.Site-specific recombinases
Cre mRNA was transcribed using pT3TS/Cre (pDB638)
as the template as described in [27,28]. For reversion of
gene trap mutations, 25–75 pg of in vitro transcribed
Cre mRNA was injected into 1-cell zebrafish embryos.
To synthesize Flp RNA, we first amplified eFLP coding
sequence using primers Bgl-Flp-F1 and XbaCla-Flp-R1,
with pCMV-Flpx9.MiDB [81] as the template. PCR prod-
uct was cloned into pJet1.2 (ThermoFisher Fermentas) and
then subcloned into pT3TS [82] to generate pDC31.
pDC31 was linearized with BamHI and transcribed using
mMessage Machine T3 in vitro transcription kit (Ambion).
600 pg of the in vitro transcribed eFLP mRNA was
injected into the yolks of 1-cell stage zebrafish embryos in
3 nL volume.Additional files
Additional file 1: Figure S1. Comparison between embryos injected
with GBT-B1 and GBT-B2 gene traps containing ^Gal4-VP16 and ^Gal4-FF
respectively. Embryos were injected with Tol2 transposase mRNA and
GBT-B1 (A) or GBT-B2 (B) plasmid DNA. At 3 dpf, random GFP-positive
embryos were photographed under identical settings and images were
processed identically.
Additional file 2: Figure S2. Enhancer trapping by GBT-B1. Solid black
boxes and lines denote exons, pale pink boxes and lines denote
untranslated regions, orange box denotes an enhancer and dashed
orange arrows indicate transcriptional activation by the enhancer.
Additional file 3: Figure S3. Expression of nsfa in the pancreas.
Comparison between GFP expression of nsfatpl6 gene trap (A, C) and nsfa
expression by whole mount in situ hybridization (B, D) in 1 dpf zebrafish
embryos. Red arrow points to pancreas.
Additional file 4: Figure S4. Phenotypes of nsf tpl6 and flrtpl19
homozygotes. A. Larvae homozygous for nsf tpl6 fail to inflate swim
bladders by 6 dpf and display greatly reduced sensitivity to touch
(Additional file 5: Movie 1). B. Comparison between a flrtpl19 homozygote
and a wild type sibling at 3 dpf. Insert displays greater magnification of
the kidney area with a cyst (white arrow).Additional file 5: Movie 1. Reduced touch response of nsfatpl6 gene
trap homozygotes. Embryos homozygous for nsfatpl6 gene trap display
very limited touch response.
Additional file 6: Movie 2. Phenotype of flrtpl19 homozygotes. Embryos
homozygous for flrtpl19 gene trap display abnormal body curvature and
other abnormalities.
Additional file 7: Figure S5. Late larval lethality of atp1a3atpl10
homozygotes. A. 5 dpf larvae homozygous for atp1a3atpl10 do not display
overt embryonic phenotypes compared to heterozygous and wild type
embryos. B. Genotyping of adult fish raised from atp1a3atpl10 incross
embryos selected for GFP fluorescence. Diagrams on the top represent
the tpl10 gene trap allele and wild type allele with expected sizes of PCR
bands indicated. Genomic primers flanking transposon integration
(Atp1a3a.9A1c.F and Atp1a3a.9A1A.R) are depicted as blue arrows,
transposon-specific primer Tol2-R5 is depicted as a black arrow. PCR
bands are shown as blue (wild type) and black (gene trap allele) dashed
lines. Short PCR extension time does not allow amplification across
GBT-B1. Below the diagram is a picture of a genotyping gel. Lanes 1 an
16, DNA ladder (Thermofisher Fermentas Cat #SM0331, sizes of relevant
bands indicated to the left). Lanes 2–15 are PCR reactions on DNA from
individual tailclips. Lanes 17 and 18 are PCR reactions performed on DNA
from pools of GFP-positive (lane 17) and GFP-negative (lane 18) embryos.
Additional file 8: Table S2. Germline excision of UAS:eGFP cassette
from nsftpl6 gene trap line. Gene trap heterozygotes were crossed to Tg
(UAS:mRFP)tpl2 and embryos were injected with 600 pg of in vitro
transcribed Flp mRNA. Embryos with significant reduction of eGFP
expression were raised to adulthood and crossed to Tg(UAS:mRFP)tpl2
again. Column 1, fish identifier. Column 2, number of embryos obtained.
Column 3, total number of RFP-positive embryos. Column 3, number of
RFP-positive embryos not expressing eGFP. Column 3, calculated
efficiency Flp-mediated eGFP excision in germline.
Additional file 9: Table S1. Primer sequences.
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